In this episode Carmen Solorzano, MD, Chair of the SSO Endocrine Disease Site Work Group, Electron Kebebew, MD, and Geoffrey Young, MD, PhD, discuss two practice changing studies regarding the management of Medullary and Anaplastic Thyroid Cancer.

Carmen Solorzano, MD, Professor of Surgery, Chair, Department of Surgery, and Director, Vanderbilt Endocrine Surgery

Geoffrey Young, MD, PhD, Chief, Head and Neck Surgery; Miami Cancer Institute

Electron Kebebew, MD, Professor and Chief, Stanford University School of Medicine

1-Efficacy of Selpercatinib in RET-Altered Thyroid Cancers.

Wirth LJ et al. N Engl J Med. 2020 Aug 27;383(9):825-835. doi: 10.1056/NEJMoa2005651.PMID: 32846061